Literature DB >> 9856498

The molecular basis of C6 deficiency in the western Cape, South Africa.

M J Hobart1, B A Fernie, K A Fijen, A Orren.   

Abstract

Deficiency of the sixth component of human complement (C6) has been reported in a number of families from the western Cape, South Africa. Meningococcal disease is endemic in the Cape and almost all pedigrees of total C6 deficiency (C6Q0) have been ascertained because of recurrent disease. We have sequenced the expressed exons of the C6 gene from selected cases and have found three molecular defects leading to total deficiency: 879delG, which is the common defect in the Cape and hitherto unreported, and 1195delC and 1936delG, which have been previously reported in African-Americans. We also show that the 879delG and 1195delC defects are associated with characteristic C6/C7 region DNA marker haplotypes, although small variations were observed. The 1936delG defect was observed only once in the Cape, but its associated haplotype could be deduced. The data from the haplotypes indicate that these three molecular defects account for the defects in all the 38 unrelated C6Q0 individuals we have studied from the Cape. We have also observed the 879delG defect in two Dutch C6-deficient kindreds, but the 879delG defect in the Cape probably did not come from The Netherlands.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9856498     DOI: 10.1007/s004390050858

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  14 in total

Review 1.  Molecular mechanisms of complement component C6 deficiency; a hypervariable exon 6 region responsible for three of six reported defects.

Authors:  A Orren
Journal:  Clin Exp Immunol       Date:  2000-02       Impact factor: 4.330

2.  High prevalence of complement component C6 deficiency among African-Americans in the south-eastern USA.

Authors:  Z Zhu; T P Atkinson; K T Hovanky; S B Boppana; Y L Dai; P Densen; R C Go; J S Jablecki; J E Volanakis
Journal:  Clin Exp Immunol       Date:  2000-02       Impact factor: 4.330

3.  Complete deficiency of the sixth complement component (C6Q0), susceptibility to Neisseria meningitidis infections and analysis of the frequencies of C6Q0 gene defects in South Africans.

Authors:  A Orren; E P Owen; H E Henderson; L van der Merwe; F Leisegang; C Stassen; P C Potter
Journal:  Clin Exp Immunol       Date:  2012-03       Impact factor: 4.330

4.  Meningococccal meningitis and complement component 6 deficiency associated with oculocutaneous albinism.

Authors:  Aydan Ikinciogullari; Mustafa Tekin; Figen Dogu; Ismail Reisli; Gonul Tanir; Zanhua Yi; Nanibaa Garrison; Murray H Brilliant; Emel Babacan
Journal:  Eur J Pediatr       Date:  2004-11-23       Impact factor: 3.183

5.  Complement factor 5 (C5) p.A252T mutation is prevalent in, but not restricted to, sub-Saharan Africa: implications for the susceptibility to meningococcal disease.

Authors:  C Franco-Jarava; D Comas; A Orren; M Hernández-González; R Colobran
Journal:  Clin Exp Immunol       Date:  2017-04-20       Impact factor: 4.330

6.  The C5 convertase is not required for activation of the terminal complement pathway in murine experimental cerebral malaria.

Authors:  Theresa N Ramos; Meghan M Darley; Sebastian Weckbach; Philip F Stahel; Stephen Tomlinson; Scott R Barnum
Journal:  J Biol Chem       Date:  2012-06-11       Impact factor: 5.157

Review 7.  Infections of people with complement deficiencies and patients who have undergone splenectomy.

Authors:  Sanjay Ram; Lisa A Lewis; Peter A Rice
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

8.  C7 deficiency in an Irish family: a deletion defect which is predominant in the Irish.

Authors:  A M O'Hara; B A Fernie; A P Moran; Y E Williams; J J Connaughton; A Orren; M J Hobart
Journal:  Clin Exp Immunol       Date:  1998-12       Impact factor: 4.330

9.  State-based surveillance to determine trends in meningococcal disease.

Authors:  Carmen Clarke; Sue Mallonee
Journal:  Public Health Rep       Date:  2009 Mar-Apr       Impact factor: 2.792

10.  Restricted genetic defects underlie human complement C6 deficiency.

Authors:  M A Dragon-Durey; V Fremeaux-Bacchi; J Blouin; D Barraud; W H Fridman; M D Kazatchkine
Journal:  Clin Exp Immunol       Date:  2003-04       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.